Aknamed offers cloud-based platform for hospital supply chain management
As per the filings, the reason behind raising the fresh round of funds is to “carry out day to day operations.”
In June 2021, Pharmeasy had also acquired 66.1% stake in listed diagnostics chain Thyrocare for INR 4,546 Cr.
API Holdings, the parent company of epharmacy platform Pharmeasy is investing INR 307 Cr in healthcare supply chain startup Aknamed. As per the regulatory filings accessed by Inc42, Aknamed will be allotting 9,75,937 equity shares at an issue price of INR 3,155.94.
As per the filings, the reason behind raising the fresh round of fund is to “carry out day to day operations.”
Founded by Saurabh Pandey and Mahadevan Narayanamoni in 2018, Aknamed offers procurement solutions to hospital chains and mid-sized standalone hospitals with the help of technology. The startup later appointed Mayank Kapoor, Shaunak Joshi and Varun Vohra as co-founders.
Earlier this year Aknamed acquired 1988 founded Vardhman Health Specialities for $35 Mn. The startup claimed that the acquisition will help Aknamed to boost its operations and allow it to expand to different parts of the country.
